Drug Shortage Report for BETNESOL RETENTION ENEMA 5MG/100ML
Report ID | 99618 |
Drug Identification Number | 02060884 |
Brand name | BETNESOL RETENTION ENEMA 5MG/100ML |
Common or Proper name | Betnesol |
Company Name | PALADIN LABS INC. |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | BETAMETHASONE |
Strength(s) | 5MG |
Dosage form(s) | ENEMA |
Route of administration | RECTAL |
Packaging size | 1 pouch |
ATC code | A07EA |
ATC description | INTESTINALANTIINFLAMMATORY AGENTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-11-22 |
Estimated end date | 2020-01-24 |
Actual end date | 2020-01-06 |
Shortage status | Resolved |
Updated date | 2020-01-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 SAINT-LAURENT, QUEBEC CANADA H4M 2P2 |
Company contact information | 1-866-340-1112 paladincs@endo.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2020-01-07 | French | Compare |
v7 | 2020-01-07 | English | Compare |
v6 | 2020-01-03 | French | Compare |
v5 | 2020-01-03 | English | Compare |
v4 | 2019-12-16 | French | Compare |
v3 | 2019-12-16 | English | Compare |
v2 | 2019-11-25 | French | Compare |
v1 | 2019-11-25 | English | Compare |
Showing 1 to 8 of 8